J9309 HCPCS Level II code: Injection, polatuzumab vedotin-piiq, 1 mg
J9309 is the HCPCS code for “Injection, polatuzumab vedotin-piiq, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9309Injection, polatuzumab vedotin-piiq, 1 mg
Short description: Inj, polatuzumab vedotin 1mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J9309 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2020
Where J9309 sits
- 1J codesDrugs administered other than orally
- 2Active code J9309Injection, polatuzumab vedotin-piiq, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9309 mean?
J9309 is the HCPCS code for “Injection, polatuzumab vedotin-piiq, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9309?
CMS lists J9309’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9309
All J codesJ9303Injection, panitumumab, 10 mgJ9304Injection, pemetrexed (pemfexy), 10 mgJ9305Injection, pemetrexed, not otherwise specified, 10 mgJ9306Injection, pertuzumab, 1 mgJ9307Injection, pralatrexate, 1 mgJ9308Injection, ramucirumab, 5 mgJ9310Injection, rituximab, 100 mgJ9311Injection, rituximab 10 mg and hyaluronidaseJ9312Injection, rituximab, 10 mgJ9313Injection, moxetumomab pasudotox-tdfk, 0.01 mgJ9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mgJ9315Injection, romidepsin, 1 mg